Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2—a study protocol for a randomized controlled trial.
Autor: | Thankachen, Shani S.1 (AUTHOR), Devasenapathy, Niveditha1 (AUTHOR), Bassi, Abhinav1 (AUTHOR), Ghosh, Arpita1 (AUTHOR), Arfin, Sumaiya1 (AUTHOR), Gummidi, Balaji1 (AUTHOR), Basheer, Aneesh2 (AUTHOR), Bangi, Ashfak3 (AUTHOR), Sahu, Dibakar4 (AUTHOR), Bhalla, Ashish5 (AUTHOR), Blesson, Merlin6 (AUTHOR), Jain, Manish7 (AUTHOR), Jha, Vivekanand1,8,9 (AUTHOR) v.jha@imperial.ac.uk |
---|---|
Zdroj: | Trials. 6/12/2024, Vol. 25, p1-11. 11p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |